Lupin gets approval to market Bepotastine Tablets in India

From Central Drugs Standard Organisation

Lupin has received approval for Bepotastine Tablets from the Central Drugs Standard Organisation. Lupin shall commence promoting the product in India shortly.

Bepotastine is a new second generation antihistamine medicine to be introduced into the Indian Pharmaceutical market which could benefit million of patients suffering from allergic symptoms.

Powered by Capital Market - Live News